Press release
The clinical trials software market is projected to be growing at a CAGR of 14%, claims Roots Analysis
Clinical Trials Software Market Report
Excessive capital expenditure and other complexities associated with the traditional clinical trials has imposed an enormous financial burden on the pharmaceutical industry. Virtual clinical trials software solutions have the potential to induce substantial digital changes in clinical research methodology, resulting in a more patient-centric, cost-effective and easy to manage approach.
To order this 270+ page report, which features 60+ figures and 50+ tables, please visit https://www.rootsanalysis.com/reports/clinical-trial-software-market.html
Key Market Insights
Over 70+ companies claim to provide clinical trials software
The companies offer clinical trials software with different features like electronic data capture, eCOA/ePRO and eConsent along with decentralized and virtual clinical trials and remote monitoring of the patients. Majority of the players based in North America offer clinical trials software followed by Europe and Asia-Pacific. Further, the market is dominated by the presence of mid-sized players (more than 40%) followed by small and large players.
Since 2016, more than 120+ partnerships have been inked by service providers
Interestingly, the maximum number of partnership agreements were inked in 2021, majority of these were service agreements (44%), followed by acquisitions/mergers (26%). Further, most of the deals were inked with players based in North America (64%).
Over 30 mergers and acquisitions were reported in this domain, during the period 2016-2021
More than 85% of these were instances of acquisitions. Further, majority of the instances involved the companies based in North America and the maximum number of deals were inked in 2019.
Over USD 492.8 million has been invested by both private and public investors, since 2016
Majority of the companies (67%) engaged in this domain primarily received funding through venture capital rounds. Further, around 98% of the funding instances were reported by players headquartered in North America.
The market is expected to grow at an annual rate close to 14% over the coming decade
The opportunity is likely to be well distributed across clinical trials software on the basis of features of software (EDC, eCOA/ePRO and eConsent) and geographies (North America, Europe and Asia-Pacific). By 2035, the clinical trials software market in North America is anticipated to grow at a relatively faster pace (39%), followed by the market in Europe (21%).
To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/clinical-trial-software-market/request-sample.html
Key Questions Answered
Who are the leading players engaged in the development of clinical trials software solutions?
Which region(s) will occupy the maximum market share in clinical trials software domain?
Who are the key venture capitalists / strategic investors funding the clinical trials software development initiatives?
Which partnership models are commonly adopted by stakeholders engaged in the development of clinical trials software solutions?
Which factors are likely to influence the evolution of this market?
How is the current and future market opportunity likely to be distributed across key market segments?
By 2035, the financial opportunity within the clinical trials software market has been analysed across the following segments:
> Features of Software
Electronic Data Capture
eCOA/ePRO
eConsent
> Analysis by Geographical Regions
North America
Europe
Asia Pacific
The research includes profiles of key players (listed below); each profile features a tabulated overview of company, product portfolio, recent developments, and an informed future outlook.
Advarra
ArisGlobal
AssistRx
Clario
IBM
IQVIA
For additional details, please visit
https://www.rootsanalysis.com/reports/clinical-trial-software-market.html or email sales@rootsanalysis.com
You may also be interested in the following titles:
1. Virtual Clinical Trial Service Providers Market, 2021-2030 (https://www.rootsanalysis.com/reports/virtual-clinical-trial-service-provides-market.html)
2. AI-based Clinical Trial Solutions Providers Market, 2020-2030 (https://www.rootsanalysis.com/reports/ai-based-clinical-trial-solutions.html)
3. Patient Recruitment and Retention Services Market (2nd Edition), 2021-2030 (https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market/245.html)
Contact Details
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
Medium: https://medium.com/@RootsAnalysis
Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/
Quora: https://rootsanalysisinsights.quora.com/
We specialise in analysing areas which have lacked quality research so far or require more focussed understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The clinical trials software market is projected to be growing at a CAGR of 14%, claims Roots Analysis here
News-ID: 2647161 • Views: …
More Releases from Roots Analysis
T-Cell Therapy Market Size to Hit USD 20.9 billion by 2035| Exclusive Report by …
Cancer is one of the leading causes of mortality across the world. As per the International Agency for Research on Cancer (IARC), by 2040, there are likely to be 27.5 million new cases and 16.3 million deaths related to cancer, annually. Although cancer therapeutics continue to be one of the most active areas, in terms of drug development, there is still a significant unmet need in this domain. In fact,…
Cancer Biologics Market: Unmet Need and Treatment Guidelines
Owing to the increasing mortality rates and growing need for novel modalities to treat oncological disorders, several researchers and industry stakeholders have shifted their focus on the development of safe and effective biologic therapies. Cancer biologics are the class of therapeutic agents, which primarily modulate immune responses or directly inhibits oncogenic pathways in malignancies. These therapies, such as monoclonal antibodies, specifically target tumor-activating genes, facilitate antibody-dependent cellular cytotoxicity and complement…
Peptide Synthesis: Supporting Next Generation Targeted Therapies
Peptides are specialized molecules composed of short chains of amino acids and are used primarily as the active ingredients in a new class of targeted therapeutics. Peptide synthesis is achieved through various advanced methodologies, including chemical processes like solid-phase (SPPS) and liquid-phase (LPPS), as well as hybrid and non-chemical approaches.
Peptides are being extensively used as therapeutics to treat various disorders, including metabolic diseases, oncological disorders, and hormonal imbalances due to…
Prefilled Syringes Market Size to Hit USD 4.97 billion by 2035| Exclusive Report …
Prefilled syringes: setting new standards for safe and efficient drug administration. With the increasing population, the incidence rates of various chronic diseases, such as diabetes, autoimmune disorders, cardiovascular disorders and oncological disorders, are witnessing an upward trend.
The global prefilled syringes market, valued at USD 3.02 billion in 2024, is project to reach USD 3.19 billion in 2025 and USD 4.97 billion by 2035, representing a CAGR of 4.5% during the…
More Releases for Clinical
Miami Clinical Research Sets the Standard for Clinical Trials
Miami Clinical Research, a frontrunner in the world of clinical trials and medical research, has emerged as the prime choice for global corporate pharmaceutical giants. With a deep understanding of the complexities of medical studies, the organization champions the crucial role of research in the evolution of transformative therapeutic interventions.
Miami, FL - Renowned as a first-rate center for professional medical exploration, Miami Clinical Research [https://miamiclinicalresearch.com] boasts state-of-the-art facilities, advanced technologies,…
E-Clinical Solutions Market: Revolutionizing Healthcare and Clinical Trials
Introduction
The e-Clinical solutions market has become a pivotal component of the healthcare and pharmaceutical industries. E-Clinical solutions refer to a set of software, tools, and platforms designed to streamline clinical trials and healthcare management. These solutions include electronic data capture (EDC), clinical trial management systems (CTMS), laboratory information management systems (LIMS), and other integrated tools that improve the efficiency, accuracy, and speed of clinical trials and healthcare services. The primary…
E-Clinical Solutions Market: Revolutionizing Clinical Trials
The e-clinical solutions market has experienced significant growth in recent years, driven by the increasing complexity of clinical trials and the need for efficient, accurate, and compliant data management. E-clinical solutions provide a comprehensive suite of tools and technologies to streamline clinical trial processes, accelerate drug development, and improve patient outcomes.
Market Size and Growth
The global e-clinical solutions market is estimated to be worth billions of dollars, with a significant portion…
Clinical Trials Management System Market Optimizing Clinical Trials: The Crucial …
Clinical Trials Management System Market to reach over USD 5.06 billion by the year 2031- Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical…
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation.
This is the premier interdisciplinary forum for…
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog …
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry.
The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinical…
